好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Acute Stroke Therapy Beyond Thrombolysis: Hypothermia and Neuroprotection

Wednesday 05/02/07
02:00 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Integrated Neuroscience
Cerebrovascular Disease and Interventional Neurology, Neural Repair/Rehabilitation
No CME available
Event Timeline
02:00 PM - 06:00 PM Abstract 001 - The HMG Co-A Reductase Inhibitor, Pravastatin, Provides Acute Neuroprotection for CA1 Pyramidal Neurons Against Oxidative Stress through Intrinsic Neural Mechanisms
02:00 PM - 06:00 PM Abstract 001 - Reduction of Stroke-Induced Astrogliosis by Noggin
02:00 PM - 06:00 PM Abstract 002 - NF-kb and MMP9 Are Associated with Pyruvate Protectionagainst Inflammatory Response in Experimental Stroke
02:00 PM - 06:00 PM Abstract 002 - Apocynin Reduces Blood-Brain Barrier Disruption in Experimental Stroke by Inhibiting NADPH Oxidase Activity, Reduces MMP-9 Expression
02:00 PM - 06:00 PM Abstract 003 - Normobaric Hyperoxia Extends the Reperfusion Window as Assessed by Quantitative Perfusion/Diffusion Weighted Imaging
02:00 PM - 06:00 PM Abstract 003 - [epsilon]PKC May Contribute to the Protective Effect of Hypothermia Against Focal Cerebral Ischemia
02:00 PM - 06:00 PM Abstract 004 - Heliox and Oxygen Reduce Infarct Volume in a Rat Model of Focal Ischemia
02:00 PM - 06:00 PM Abstract 004 - Biomarkers from a Petri Dish: The Feasibility of Proteomic Screening for Endothelial Response to Oxidative Stress
02:00 PM - 06:00 PM Abstract 005 - Gamma-hydroxybutyrate (GHB) Promotes Functional Recovery and Alters Expression of Neuroplasticity-related Genes in a Mouse-model of Stroke
02:00 PM - 06:00 PM Abstract 005 - Modulation of Neuroinflammation by Human Cord Blood Stem Cells after Stroke
02:00 PM - 06:00 PM Abstract 006 - The ALIAS Trial: A Phase III Randomized Multicenter Clinical Trial of Albumin-Neuroprotection in Acute Ischemic Stroke: Rationale, Study Design, and Progress Report
02:00 PM - 06:00 PM Abstract 006 - MR Evidence of Reduced Lesion Volume after Human Albumin Therapy for Acute Ischemic Stroke. The ALIAS Pilot Trial
02:00 PM - 06:00 PM Abstract 007 - The Effect of Early Statin Use in Acute Ischemic Stroke on Immediate and 3-month Outcome
02:00 PM - 06:00 PM Abstract 008 - Peripheral Blood Levels of S100A8 Can Distinguish Acute Ischemic Stroke Patients
02:00 PM - 06:00 PM Abstract 009 - A Phase I Study of Eptifibatide in Acute Ischemic Stroke
02:00 PM - 06:00 PM Abstract 010 - Eptifibatide for Deteriorating Lacunar Infarcts
Faculty Disclosures
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Midori A. Yenari, MD, FAAN No disclosure on file
Marc Fisher, MD, FAAN Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Michael D. Hill, MD Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Myron D. Ginsberg, MD, FAAN No disclosure on file
No disclosure on file
Elizabeth A. Noser, MD No disclosure on file
Aslam Khaja, MD Dr. Khaja has nothing to disclose.
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Hashem Shaltoni, MD Dr. Shaltoni has nothing to disclose.
Kachikwu O. Illoh, MD No disclosure on file
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Christian Baumann, MD No disclosure on file
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Roi A. Wallis, MD No disclosure on file
Teresa A. Allison No disclosure on file
Ja-Seong Koo, MD No disclosure on file
Curie Chung, MD No disclosure on file
Salvador Cruz-Flores, MD, FAAN The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Byung-kun Kim, MD Dr. Kim has nothing to disclose.
Yuko Palesch No disclosure on file
Xiannan Tang, MD, PhD No disclosure on file
Maiken Nedergaard, MD, DMSc Maiken Nedergaard, MD, DMSc has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CNS2. Maiken Nedergaard, MD, DMSc has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CNS2.
Ross Mitchell No disclosure on file
Hen Hallevi, MD No disclosure on file
Jung-Ju Lee, MD, PhD No disclosure on file
MingMing Ning, MD No disclosure on file
Hee-Joon Bae, MD No disclosure on file
Steven A. Goldman, MD, PhD No disclosure on file
Nils Henninger, MD, PhD, FANA, FWSO Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Myrobalan Inc.
Andrew D. Barreto, MD No disclosure on file
Renee Martin No disclosure on file
Andrew M. Demchuk, MD Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care.
Gary Steinberg, MD, PhD Dr. Steinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SanBio. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zeiss. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgical Theater. Dr. Steinberg has received research support from National Institutes of Health. Dr. Steinberg has received research support from California Institute of Regenerative Medicine. Dr. Steinberg has received intellectual property interests from a discovery or technology relating to health care.
Dirk Hermann No disclosure on file
W. Michael Panneton, PhD No disclosure on file
Jong-Moo Park, MD No disclosure on file
Eng Lo, MD Eng Lo, MD has nothing to disclose.
Ohyun Kwon No disclosure on file
Raymond A. Swanson, MD No disclosure on file
Caitlin Wright No disclosure on file
Brandon R. Barton, MD, FAAN Dr. Barton has nothing to disclose.
Alexander Sherman The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Claudio L. Bassetti, MD No disclosure on file
Chad Carlson, MD, FAAN Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Ines Gonzalez No disclosure on file
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Aida Orviz-García, MD Dr. Orviz-García has nothing to disclose.
Patricia C. Dugan, MD No disclosure on file
Aynara Wulsin, MD, PhD No disclosure on file